Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CarDiac MagnEtic Resonance for Primary Prevention Implantable CardioVerter DebrillAtor ThErapy: an International Registry

NCT03352648 is registered in ClinicalTrials.gov with Gianluca Pontone, MD, PhD as lead sponsor.

NCT NCT03352648
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03352648 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CarDiac MagnEtic Resonance for Primary Prevention Implantable CardioVerter DebrillAtor ThErapy: an International Registry
Lead sponsor
Gianluca Pontone, MD, PhD
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2007
Completion date
December 31, 2020
Enrollment
4,000 (estimated)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, left ventricular systolic dysfunction